ATE393624T1 - Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs - Google Patents

Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs

Info

Publication number
ATE393624T1
ATE393624T1 AT02708107T AT02708107T ATE393624T1 AT E393624 T1 ATE393624 T1 AT E393624T1 AT 02708107 T AT02708107 T AT 02708107T AT 02708107 T AT02708107 T AT 02708107T AT E393624 T1 ATE393624 T1 AT E393624T1
Authority
AT
Austria
Prior art keywords
treatment
cancer
compositions containing
sesquiterpene
containing sesquiterpene
Prior art date
Application number
AT02708107T
Other languages
English (en)
Inventor
Andre Pichette
Jean Legault
Jean-Claude Madelmont
Original Assignee
F P L Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F P L Pharma Inc filed Critical F P L Pharma Inc
Application granted granted Critical
Publication of ATE393624T1 publication Critical patent/ATE393624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02708107T 2001-03-28 2002-03-28 Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs ATE393624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002342403A CA2342403A1 (en) 2001-03-28 2001-03-28 Sesquiterpene derivatives as anticancer agents

Publications (1)

Publication Number Publication Date
ATE393624T1 true ATE393624T1 (de) 2008-05-15

Family

ID=4168717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02708107T ATE393624T1 (de) 2001-03-28 2002-03-28 Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs

Country Status (8)

Country Link
US (2) US20040191342A1 (de)
EP (1) EP1372677B1 (de)
JP (1) JP2004525152A (de)
AT (1) ATE393624T1 (de)
CA (1) CA2342403A1 (de)
DE (1) DE60226313T2 (de)
ES (1) ES2305215T3 (de)
WO (1) WO2002078719A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356438A1 (en) * 2001-09-05 2003-03-05 Andre Pichette Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
JP5116942B2 (ja) * 2003-04-22 2013-01-09 株式会社マザー＆チャイルド プロジェステロンの変化に伴う不快症状の改善用組成物、及びその芳香治療用組成物、並びにその芳香治療用具
JP4717362B2 (ja) * 2004-03-04 2011-07-06 株式会社フローラ 細胞分化誘導剤
JP2008514649A (ja) 2004-10-01 2008-05-08 アシエ・ラボラトリオス・フアルマセウチコス・エシ・アー 薬剤の製造並びに炎症及び炎症性疼痛の身体状態の治療におけるカリオフィレンの使用
CN101568503B (zh) * 2006-12-21 2015-02-04 纳幕尔杜邦公司 石竹烯的氢化
WO2008144880A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
GB0809046D0 (en) * 2008-05-19 2008-06-25 Reynolds Max Cancer treatment
KR101440855B1 (ko) * 2012-05-31 2014-09-18 구을리주식회사 솔잎 추출물로부터 분리된 공지화합물을 함유하는 암질환 예방 및 치료용 조성물
KR101440853B1 (ko) * 2012-05-31 2014-09-18 구을리주식회사 솔잎 추출물로부터 분리된 공지 화합물을 함유하는 인체 파필로마바이러스（ｈｐｖ）로 기인한 자궁경부암, 또는 후두암 예방 및 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB395007A (en) * 1930-10-04 1933-07-05 Joao Da Veiga Soares Curative specifics containing sulphonated derivatives of santalene or caryophyllene
CN1130062A (zh) * 1995-12-29 1996-09-04 杨得坡 氧化丁香烯用作抗真菌剂
FR2808196A1 (fr) * 2000-04-27 2001-11-02 Andre Rougereau Nouveaux medicaments a base de melanges de sesquiterpenes
FR2811899B1 (fr) * 2000-07-20 2003-02-07 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques

Also Published As

Publication number Publication date
US20040191342A1 (en) 2004-09-30
WO2002078719A1 (en) 2002-10-10
DE60226313D1 (de) 2008-06-12
CA2342403A1 (en) 2002-09-28
DE60226313T2 (de) 2009-06-25
EP1372677A1 (de) 2004-01-02
US20090197949A1 (en) 2009-08-06
EP1372677B1 (de) 2008-04-30
ES2305215T3 (es) 2008-11-01
JP2004525152A (ja) 2004-08-19

Similar Documents

Publication Publication Date Title
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
HK1068136A1 (en) Muscarinic antagonists
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
IS6658A (is) Ný efnasambönd
GEP20084572B (en) Novel quinoline derivatives
MY129348A (en) Stable polymorph of n-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4- quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
IS6520A (is) Ný efnasambönd
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
HUP0500478A2 (hu) Taxánszármazékokat tartalmazó tumorellenes készítmények
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK1056704T3 (da) Antitumormidler
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
DOP2003000621A (es) Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa
SE0003476D0 (sv) Compounds
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
NO20042729L (no) Heksasykliske forbindelser
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties